| Bioactivity | Bemoradan (compound 10a) is an orally active and selective canine Phosphodiesterase (PDE) fraction III inhibitor. Bemoradan is a long-acting, potent, inotropic vasodilator and a novel cardiotonic agent, and can be used in congestive heart failure research[1]. |
| Name | Bemoradan |
| CAS | 112018-01-6 |
| Formula | C13H13N3O3 |
| Molar Mass | 259.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Combs DW, et al. 6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents. J Med Chem. 1990 Jan;33(1):380-6. |
Bemoradan
CAS: 112018-01-6 F: C13H13N3O3 W: 259.26
Bemoradan (compound 10a) is an orally active and selective canine Phosphodiesterase (PDE)fraction III inhibitor. Bemorad
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.